论文部分内容阅读
自1997年11月～1998年3月我们用自力霉素加凝血酶胸腔内注射治疗癌性胸腔积液21例,取得良好的疗效,现报告如下。 1 选例标准 经病理学和(或)细胞学证实的由恶性肿瘤所致的胸腔积液住院患者,无明显心脏及肝肾功能障碍,Karnof sky评分为50分以上,预计生存期在2个月以上。 2 临床资料 癌性胸腔积液患者21例,男14例,女7例;年龄27～84岁,平均年龄58岁。其中非小细胞肺癌患
From November 1997 to March 1998, we treated 21 cases of cancerous pleural effusions with intramuscular injection of thrombin and thrombin, and obtained good results. The report is as follows. 1 Optional criteria Hospitals with malignant pleural effusions confirmed by pathology and/or cytology have no significant cardiac and hepatorenal dysfunction. The Karnof sky score is 50 points or more. The estimated survival time is 2 More than month. 2 Clinical data 21 patients with cancerous pleural effusion, 14 males and 7 females; aged 27 to 84 years, mean age 58 years. Among them, patients with non-small cell lung cancer